Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine
Phase 1
Recruiting
- Conditions
- Vaccine ResponseCOVID-19 VaccineImmune Response to Covid 19 Vaccination
- Interventions
- First Posted Date
- 2025-02-11
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 75
- Registration Number
- NCT06821100
- Locations
- πΊπΈ
Houston Methodist Hospital, Houston, Texas, United States
Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells
Phase 1
Not yet recruiting
- Conditions
- Anterior Cruciate Ligament Reconstruction
- Interventions
- Biological: Autologous Mesenchymal Stromal Cells
- First Posted Date
- 2025-01-29
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 15
- Registration Number
- NCT06798623
MRI Guided Management of Occlusive Peripheral Arterial Disease
Recruiting
- Conditions
- Peripheral Vascular Diseases
- First Posted Date
- 2025-01-17
- Last Posted Date
- 2025-01-17
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 175
- Registration Number
- NCT06782100
- Locations
- πΊπΈ
Houston Methodist Hospital, Houston, Texas, United States
Non-invasive VNS in Stroke Recovery
Not Applicable
Recruiting
- Conditions
- Stroke
- First Posted Date
- 2025-01-07
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 60
- Registration Number
- NCT06761404
- Locations
- πΊπΈ
Houston Methodist Research Institute, Houston, Texas, United States
IO Vancomycin Spine
Phase 2
Not yet recruiting
- Conditions
- Lumbar Fusion Surgery
- Interventions
- Drug: Intraosseous VancomycinDrug: Intravenous Vancomycin
- First Posted Date
- 2024-12-27
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 30
- Registration Number
- NCT06748144
- Locations
- πΊπΈ
Houston Methodist Hospital, Houston, Texas, United States
Low-Dose Lidocaine Infusion for Acute Pain Management Pilot Study
Phase 4
Completed
- Conditions
- Postoperative Pain Management
- Interventions
- Drug: Low-Dose Lidocaine
- First Posted Date
- 2024-12-10
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 18
- Registration Number
- NCT06725485
- Locations
- πΊπΈ
Houston Methodist Hospital, Houston, Texas, United States
Blood Flow Restriction (BFR) Training on the Ulnar Collateral Ligament (UCL)
Not Applicable
Recruiting
- Conditions
- HealthyHealthy Male and Female SubjectsHealthy Volunteers
- First Posted Date
- 2024-10-30
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 50
- Registration Number
- NCT06664827
- Locations
- πΊπΈ
Houston Methodist Hospital, Houston, Texas, United States
Bone Stimulator for Spondylolysis
Not Applicable
Not yet recruiting
- Conditions
- SpondylolysisSymptomatic SpondylolysisAthletes
- First Posted Date
- 2024-10-30
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 48
- Registration Number
- NCT06666608
- Locations
- πΊπΈ
Houston Methodist Hospital, Houston, Texas, United States
Intraosseous (IO) Cefazolin and Vancomycin in Primary Total Knee Arthroplasty (TKA)
Phase 1
Recruiting
- Conditions
- Total Knee Arthroplasty
- Interventions
- Drug: IO Administration of CefazolinDrug: IV Administration of CefazolinDrug: IO Administration of VancomycinDrug: IV Administration of Vancomycin
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 40
- Registration Number
- NCT06640491
- Locations
- πΊπΈ
Houston Methodist Hospital, Houston, Texas, United States
Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer
- First Posted Date
- 2024-08-22
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 15
- Registration Number
- NCT06566443
- Locations
- πΊπΈ
Houston Methodist Neal Cancer Center, Houston, Texas, United States